BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1208631)

  • 1. Modification of avoidance behavior in 6-hydroxydopamine-treated rats by stimulation of central noradrenergic and dopaminergic receptors.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):887-93. PubMed ID: 1208631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The actions of dopaminergic and noradrenergic antagonists on conditioned avoidance responses in intact and 6-hydroxydopamine-treated rats.
    Taboada ME; Souto M; Hawkins H; Monti JM
    Psychopharmacology (Berl); 1979 Mar; 62(1):83-8. PubMed ID: 108752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural supersensitivity to apomorphine following cerebral dopaminergic denervation by 6-hydroxydopamine.
    Nahorski SR
    Psychopharmacologia; 1975 May; 42(2):159-62. PubMed ID: 1172249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of the 6-hydroxydopamine-induced suppression of a CAR by drugs facilitating central catecholaminergic mechanisms.
    Ruiz M; Monti JM
    Pharmacology; 1975; 13(4):281-6. PubMed ID: 1187753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of intraventricular administration of 6-hydroxydopamine on behavior of rats in approach and avoidance procedures: Reversal of avoidance decrements by diazepam.
    Beer B; Lenard LG
    Pharmacol Biochem Behav; 1975; 3(5):879-86. PubMed ID: 1208630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

  • 11. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine depletion by 6-hydroxydopamine prevents conditioned taste aversion induced by methylamphetamine but not lithium chloride.
    Wagner GC; Foltin RW; Seiden LS; Schuster CR
    Pharmacol Biochem Behav; 1981 Jan; 14(1):85-8. PubMed ID: 7465611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats.
    Stricker EM; Zigmond MJ
    J Comp Physiol Psychol; 1974 Jun; 86(6):973-94. PubMed ID: 4836848
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal by L-dopa of impaired learning due to destruction of the dopaminergic nigro-neostriatal projection.
    Zis AP; Fibiger HC; Phillips AG
    Science; 1974 Sep; 185(4155):960-2. PubMed ID: 4471715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical regulation of feeding in the rat: facilitation by alpha-noradrenergic, but not dopaminergic, receptor stimulants.
    Ritter S; Wise D; Stein L
    J Comp Physiol Psychol; 1975 Feb; 88(2):778-84. PubMed ID: 239031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of dorsal bundle injections of 6-hydroxydopamine on avoidance responding in rats.
    Fibiger HC; Mason ST
    Br J Pharmacol; 1978 Dec; 64(4):601-5. PubMed ID: 728687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat.
    Pycock C
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):15-22. PubMed ID: 560634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the noradrenergic and the dopaminergic receptors in the mechanism of the avoidance reflex in rats.
    Plech A; Herman ZS; Wierzbicki A
    Acta Med Pol; 1975; 16(4):225-30. PubMed ID: 1199799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.